Webinar: Fit for Local Context? Establishing or Improving Deliberative Processes for HTA
September 7, 2022
Pharma, biotech, and other stakeholders are increasingly being involved in deliberative processes for health technology assessment decisions, but navigating these interactions is not always clear. ISPOR and Health Technology Assessment International (HTAi) recently released a guidance for deliberative processes. This guidance and the thought processes behind it will be laid out in an upcoming webinar on September 30th.
According to ISPOR, “This webinar, led by the task force co-chairs, will focus on why a joint HTAi-ISPOR Task Force was formed to develop guidance, they will present the minimum set of considerations on the use of deliberative processes in HTA (checklist), and the approach used. During the webinar, participants will have the opportunity to discuss what efforts could be made to ensure the appropriate use and uptake of the guidance, potential gaps and what more might be needed.”
To register, click here.
(Source: ISPOR, September 7th, 2022)